By Natasha Persaud
Heart-alone transplant recipients with pre-existing kidney impairment have “unacceptably high” risks of progressing to end-stage kidney disease (ESKD) requiring renal replacement therapy and dying, investigators warned at the 2023 American Transplant Congress in San Diego, California.
Using the 2000-2018 Scientific Registry of Transplant Recipients, Rose Mary Attieh, MD, of the Mayo Clinic in Jacksonville, Florida, and colleagues identified 3391 first-time recipients of a heart-only transplant who had a low baseline estimated glomerular filtration rate (eGFR; in mL/min/1.73m2).
Read the full story in Renal & Urology News.
